These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17950346)

  • 1. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.
    Zeng X; El-Amm JM; Doshi MD; Singh A; Morawski K; Cincotta E; Losanoff JE; West MS; Gruber SA
    Surgery; 2007 Oct; 142(4):538-44; discussion 544-5. PubMed ID: 17950346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients.
    Gruber SA; West MS; Sillix DH; El-Amm JM; Garnick J; Morawski K; Haririan A
    Surgery; 2005 Oct; 138(4):772-8; discussion 778-9. PubMed ID: 16269308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term experience with early steroid withdrawal in African-American renal transplant recipients.
    Haririan A; Sillix DH; Morawski K; El-Amm JM; Garnick J; Doshi MD; West MS; Gruber SA
    Am J Transplant; 2006 Oct; 6(10):2396-402. PubMed ID: 16869806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results.
    Anil Kumar MS; Moritz MJ; Saaed MI; Heifets M; Sustento-Reodica N; Fyfe B; Kumar A
    Am J Transplant; 2005 Aug; 5(8):1976-85. PubMed ID: 15996248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.
    Aull MJ; Dadhania D; Afaneh C; Leeser DB; Hartono C; Lee JB; Serur D; Del Pizzo JJ; Suthanthiran M; Kapur S
    Transplantation; 2012 Oct; 94(8):837-44. PubMed ID: 23001353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy.
    Anil Kumar MS; Khan S; Ranganna K; Malat G; Sustento-Reodica N; Meyers WC
    Am J Transplant; 2008 Mar; 8(3):574-85. PubMed ID: 18294153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic differences in clinical response to corticosteroid treatment of acute renal allograft rejection.
    Vasquez EM; Benedetti E; Pollak R
    Transplantation; 2001 Jan; 71(2):229-33. PubMed ID: 11213064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Knauss TC; Bodziak KA; Weigel K; Rodriguez V; Seaman D; Siegel C; Valente J; Schulak JA
    Transplantation; 2003 Sep; 76(6):938-42. PubMed ID: 14508357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus.
    Hricik DE; Augustine JJ; Knauss TC; Bodziak KA; Aeder M; Siegel C; Schulak JA
    Transplantation; 2007 Feb; 83(3):277-81. PubMed ID: 17297401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.
    Gaber AO; Moore LW; Alloway RR; Woodle ES; Pirsch J; Shihab F; Henning A; Fitzsimmons W; Holman J; Reisfield R; First MR;
    Transplantation; 2013 Feb; 95(4):573-9. PubMed ID: 23423269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of 6-month protocol renal biopsy under modern immunosuppression.
    Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
    Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome predictors in African-American deceased-donor renal allograft recipients.
    Brown KL; El-Amm JM; Doshi MD; Singh A; Cincotta E; Morawski K; Losanoff JE; West MS; Gruber SA
    Clin Transplant; 2009; 23(4):454-61. PubMed ID: 19191806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy.
    Anil Kumar MS; Heifets M; Fyfe B; Saaed MI; Moritz MJ; Parikh MH; Kumar A
    Transplantation; 2005 Sep; 80(6):807-14. PubMed ID: 16210969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.